GTF Insider Trading Activity and SEC Form 4 Filings
GTF insider trading summary
No open-market insider purchases or sales of Cytomedix Inc (GTF) have been reported on SEC Form 4 in the past 12 months.
Latest GTF insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 25, 2011 | David Emerson Jorden | Director | Buy | $8K (17,000 @ $0.48) |
| Jan 24, 2011 | David Emerson Jorden | Director | Buy | $24K (52,000 @ $0.47) |
| Dec 27, 2010 | David Emerson Jorden | Director | Buy | $6K (12,500 @ $0.47) |
| Dec 22, 2010 | David Emerson Jorden | Director | Buy | $6K (12,500 @ $0.46) |
| Dec 21, 2010 | David Emerson Jorden | Director | Buy | $10K (22,000 @ $0.45) |
| Dec 17, 2010 | David Emerson Jorden | Director | Buy | $15K (32,000 @ $0.46) |
| Dec 17, 2010 | David Emerson Jorden | Director | Buy | $13K (27,500 @ $0.47) |
| Dec 16, 2010 | David Emerson Jorden | Director | Buy | $7K (14,000 @ $0.49) |
| Dec 15, 2010 | David Emerson Jorden | Director | Buy | $7K (15,000 @ $0.48) |
| Dec 14, 2010 | David Emerson Jorden | Director | Buy | $7K (15,500 @ $0.47) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.